Results 121 to 130 of about 107,308 (356)

Protective vaccination in the horse against _Streptococcus equi_ with recombinant antigens [PDF]

, 2009
_Streptococcus equi_ subspecies _equi_ (_S. equi_) is a clonal, equine host-adapted pathogen of global importance that causes a highly contagious suppurative lymphodendopathy of the head and neck, more commonly known as Strangles.
Andrew Waller, Bengt Guss, Carl Robinson, Jan-Ingmar Flock, Ken Smith, Lars Frykberg, Margareta Flock   +6 more
core   +1 more source

DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus [PDF]

, 2013
Anna Gil, Siyuan Shen, Scott Coley, Laura Gibson, Don J. Diamond, Shixia Wang, Shan Lu   +6 more
openalex   +1 more source

Engineering Immune Cell to Counteract Aging and Aging‐Associated Diseases

Advanced Science, EarlyView.
This review highlights a paradigm shift in which advanced immune cell therapies, initially developed for cancer, are now being harnessed to combat aging. By engineering immune cells to selectively clear senescent cells and remodel pro‐inflammatory tissue microenvironments, these strategies offer a novel and powerful approach to delay age‐related ...
Jianhua Guo, Lanjie Lei, Ying Jin, Lan Su, Shumao Cui, Liyun Shi   +5 more
wiley   +1 more source

Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between naïve horses and pretreated horses with the live-attenuated African horse sickness vaccine [PDF]

, 2022
Narongsak Chaiyabutr, Suphot Wattanaphansak, Rachod Tantilerdcharoen, Surasak Akesowan, Suraseha Ouisuwan, Darm Naraporn   +5 more
openalex   +1 more source

Live-attenuatedYersinia pestisvaccines

Expert Review of Vaccines, 2013
Plague caused by Yersinia pestis is one of the most dangerous infectious diseases. There is no ideal plague vaccine available for human use, but a number of licensed killed whole-cell and live-attenuated vaccines have been available in the past. Currently, there are a number of vaccines under development, including live-attenuated, DNA and subunit ...
Xiaoyi, Wang, Xuecan, Zhang, Dongsheng, Zhou, Ruifu, Yang   +3 more
openaire   +2 more sources

A Prussian Blue Nanozyme‐Adjuvanted Vaccine Presenting Phosphocholine Antigens for Induction of Immunotolerance in Inflammatory Bowel Disease

Advanced Science, EarlyView.
This study developed a novel nano‐vaccine (Ferritin‐PC@PBNZs) comprising a ferritin‐based scaffold for the multivalent display of phosphorylcholine (PC) antigens, integrated with Prussian blue nanozymes (PBNZs) as a potent adjuvant. By leveraging the ferritin carrier for high‐density and ordered antigen display, the nano‐vaccine significantly augments ...
Jingyi Sheng, Yubo Huang, Xinyue Li, Yin Liu, Yuehuang Wu, Yuxin Zhang, Ning Gu   +6 more
wiley   +1 more source

Live Attenuated Poliomyelitis Vaccine [PDF]

Public Health Reports (1896-1970), 1959
openaire   +3 more sources

Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines

, 2021
Michael E. Wechsler, Adelmir Souza‐Machado, Christine Xu, Xuezhou Mao, Upender Kapoor, Faisal A. Khokhar, John T. O’Malley, Christopher D. Petro, Veronica Mas Casullo, Leda Mannent, Paul J. Rowe, Juby A. Jacob‐Nara, Marcella Ruddy, Elizabeth Laws, Lisa A. Purcell, Megan Hardin   +15 more
openalex   +1 more source

Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters [PDF]

, 2022
Xueqiao Liu, Hong-Su Park, Yumiko Matsuoka, Celia Santos, Lijuan Yang, Cindy Luongo, Ian N. Moore, Reed F. Johnson, Nicole L. Garza, Peng Zhang, Paolo Lusso, Sonja M. Best, Ursula J. Buchholz, Cyril Le Nouën   +13 more
openalex   +1 more source

Risk Factors for Small‐for‐Size Syndrome Grade B/C After Simultaneous Splenectomy in Adult Living‐Donor Liver Transplantation

Annals of Gastroenterological Surgery, EarlyView.
In a single‐center cohort of 577 adult LDLT recipients who underwent simultaneous splenectomy, clinically significant SFSS grade B/C (ILTS‐iLDLT‐LTSI 2023) occurred in 18.2% and was associated with inferior graft survival. Multivariate analysis identified MELD ≥ 30, NLR ≥ 4.5, and donor age ≥ 50 years as independent risk factors, which risk rising ...
Kyohei Yugawa, Takeo Toshima, Shinji Itoh, Takashi Motomura, Shohei Yoshiya, Norifumi Iseda, Tomoharu Yoshizumi   +6 more
wiley   +1 more source